CytomX (CTMX) 2025 Earnings Outlook for Investors Worldwide
CytomX sits at a crossroads as 2025 earnings unfold, with pipeline updates, collaboration deals, and cost discipline ...
Learn the meaning behind the Investor Sentiment Index readings, what drives changes, and how to apply this knowledge to investment decisions.
23,759 articlesCytomX sits at a crossroads as 2025 earnings unfold, with pipeline updates, collaboration deals, and cost discipline ...
Tilray shifted from cannabis focus to a BrewDog partnership in search of diversification. But early UK sales data rai...
Teva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
A former Google engineer who left India builds Nebula AI into a $7.2 billion AI powerhouse in the U.S., highlighting ...
Bloom Energy has sprinted higher this year on an AI-powered energy story. As a late entrant, you’ll want a clear view...
As the first half 2026 over wraps up, AI stocks show a rotating leadership. This article highlights two compelling be...
Netflix stock has fallen from its peak, heightening focus on engagement metrics. This guide breaks down what to watch...
An unexpected move by Etsy’s board member sparked questions about insider trading activity. This article breaks down ...
PayPal sits near $42 after a tough year, sparking a lively debate on whether the stock is a bargain or a trap as Q4 r...
Long-running dividend growers are showing resilience as 2026 markets churn. AWR and NFG lead a small group with 50+ y...
A senior macro investor warns that the global order is entering a perilous stage of the Big Cycle, likely to test mar...
Could a bold thesis around Oklo Inc. unlock life-changing gains? This forward-looking guide breaks down why nuclear e...